Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. - Galanello,R.; Piga,A.; Alberti,D.; Rouan,MC.; Bigler,H.; Sechaud,R. (J Clin Pharmacol, 2003)